Nippon Shinyaku - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsNippon Shinyaku

Nippon Shinyaku

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Viltepso	Viltolarsen	2020-08-12	2031	Duchenne muscular dystrophy

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

duchenne muscular dystrophy

,

muscular dystrophies

Aglatimagene besadenovec

renal cell carcinoma

,

colonic neoplasms

,

,

urethral neoplasms

,

transitional cell carcinoma

,

neuroendocrine carcinoma

,

,

,

non-small-cell lung carcinoma

,

urinary bladder neoplasms

,

urologic neoplasms

,

small cell lung carcinoma

,

breast neoplasms

,

,

,

neuroendocrine tumors

,

ovarian neoplasms

,

uterine cervical neoplasms

,

small cell carcinoma

,

,

triple negative breast neoplasms

,

colorectal neoplasms

,

hepatocellular carcinoma

,

liver neoplasms

,

squamous cell carcinoma

,

,

disease progression

,

squamous cell carcinoma of head and neck

,

,

pancreatic neoplasms

,

endometrial neoplasms

,

stomach neoplasms

,

head and neck neoplasms

,

esophageal neoplasms

,

ovarian epithelial carcinoma

,

neoplasm metastasis

,

hypersensitivity

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

prostatic hyperplasia

,

,

disease susceptibility

Sodium chloride

healthy volunteers/patients

,

,

essential thrombocythemia

,

polycythemia vera

,

primary myelofibrosis

,

,

Microcrystalline cellulose

,

small cell lung carcinoma

,

,

falciparum malaria

,

,

hepatic insufficiency

,

myelodysplastic syndromes

,

,

,

lymphoid leukemia

,

b-cell chronic lymphocytic leukemia

,

dermatomyositis

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

non-hodgkin lymphoma

,

,

,

,

,

,

,

cerebral hemorrhage

,

hemorrhagic stroke

,

essential thrombocythemia

,

polycythemia vera

,

primary myelofibrosis

,

,

,

lupus nephritis

,

,

peritoneal neoplasms

,

intestinal obstruction

,

precursor t-cell lymphoblastic leukemia-lymphoma

,

t-cell leukemia

,

b-cell leukemia

,

basal cell carcinoma

,

,

basal cell nevus syndrome

,

basal cell neoplasms

,

,

,

graft vs host disease

,

bronchiolitis obliterans syndrome

,

multiple myeloma

,

plasma cell neoplasms

,

alzheimer disease

,

cognitive dysfunction

,

,

renal insufficiency

,

chronic renal insufficiency

,

kidney diseases

,

,

hyperphosphatemia

,

myeloid leukemia acute

,

myeloid leukemia

,

chronic inflammatory demyelinating polyradiculoneuropathy

,

polyradiculoneuropathy

,

human influenza

,

renal cell carcinoma

,

hepatocellular carcinoma

,

,

liver neoplasms

,

gastrointestinal stromal tumors

,

,

multiple sclerosis

,

,

relapsing-remitting multiple sclerosis

,

kidney transplantation

,

type 2 diabetes mellitus

,

chronic progressive multiple sclerosis

,

diabetes mellitus

,

neoplasm metastasis

,

healthy volunteers/patients

,

,

retinal vein occlusion

,

nerve degeneration

,

,

,

depressive disorder

,

neurobehavioral manifestations

,

,

pituitary acth hypersecretion

,

acth-secreting pituitary adenoma

,

,

,

,

cataract extraction

,

capsule opacification

,

,

disease progression

essential thrombocythemia

,

polycythemia vera

,

primary myelofibrosis

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use